Gene: Lgals8
Official Full Name: lectin, galactose binding, soluble 8provided by MGI
Gene Summary: Enables carbohydrate binding activity. Acts upstream of or within T cell costimulation and plasma cell differentiation. Predicted to be located in cytosol. Predicted to be active in cytoplasm. Orthologous to human LGALS8 (galectin 8). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04047 | LGALS8 Knockout cell line (HeLa) | Human | LGALS8 | 1:3~1:6 | Negative | Online Inquiry |
KO04048 | LGALS8 Knockout cell line (HCT 116) | Human | LGALS8 | 1:2~1:4 | Negative | Online Inquiry |
KO04049 | LGALS8 Knockout cell line (HEK293) | Human | LGALS8 | 1:3~1:6 | Negative | Online Inquiry |
KO04050 | LGALS8 Knockout cell line (A549) | Human | LGALS8 | 1:3~1:4 | Negative | Online Inquiry |
Lgals8 Gene Knockout Cell Lines represent a significant advancement in the study of glycan-binding proteins and their associated biological pathways. These specialized cell lines have been engineered to selectively knockout the Lgals8 gene, which encodes for the galectin-8 protein—a critical player in various cellular processes, including cell adhesion, apoptosis, and immune response regulation. The knockout mechanism leverages CRISPR/Cas9 technology, ensuring precise alterations in the genomic sequence to facilitate extensive research into the functional ramifications of Lgals8 deficiency.
The primary function of Lgals8 gene knockout cell lines is to provide researchers with a robust platform to investigate the role of galectin-8 in both normal and pathophysiological states. By analyzing phenotypic changes in these cell lines, scientists can examine the protein’s involvement in cancer progression, fibrosis, and autoimmune diseases. The ability to model Lgals8's absence allows for a clearer understanding of its therapeutic potential and mechanisms-of-action which can inform drug development and targeted therapies.
The scientific importance of Lgals8 gene knockout cell lines extends across various fields—ranging from fundamental biology to translational medicine. In clinical settings, these cell lines can aid in validating biomarkers for disease, advancing cell-based therapies, or evaluating the efficacy of new treatment modalities. Compared to traditional cell lines that may retain the Lgals8 expression, these knockout lines offer unparalleled insights due to their specificity and targeted capabilities.
A key advantage of Lgals8 gene knockout cell lines is their reliability and reproducibility. They allow for high-throughput screening and can be employed in diverse assays, including in vitro drug testing and mechanistic studies, making them indispensable tools for drug discovery and biomedical research. Furthermore, they have been optimized to minimize off-target effects, enhancing the validity of experimental results.
In a world where precise genetic tools are paramount for scientific advancement, Lgals8 gene knockout cell lines provide researchers and clinicians with invaluable resources for exploring novel therapeutic avenues. By focusing on delivering high-quality products derived from robust scientific expertise, our company is dedicated to supporting the innovative spirit of the research community, contributing significantly to advancements in health and disease understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.